Home/Filings/4/0001609351-19-000015
4//SEC Filing

Mingozzi Federico 4

Accession 0001609351-19-000015

CIK 0001609351other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 9:45 PM ET

Size

7.7 KB

Accession

0001609351-19-000015

Insider Transaction Report

Form 4
Period: 2019-01-15
Mingozzi Federico
Chief Scientific Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-01-15+35,00035,000 total
    Exercise: $42.73Exp: 2029-01-15Common Stock (35,000 underlying)
  • Award

    Restricted Stock Units

    2019-01-15+10,00010,000 total
    Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]25% vests January 15, 2020 and the remainder vests in equal annual installments over the following three years.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning January 15, 2020. Vested shares will be delivered to the reporting person annually on the vesting date.

Issuer

Spark Therapeutics, Inc.

CIK 0001609351

Entity typeother

Related Parties

1
  • filerCIK 0001732126

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 9:45 PM ET
Size
7.7 KB